Sequase XR 400 mg, Retardtabletten - 60 Tablette(n) Swissmedic Key 63255008 CM Registration Holder Cheplapharm Schweiz GmbH Name Sequase XR 400 mg, Retardtabletten Date of registration 01.10.2013 Original/Generic Generic Introduction of Sequence 01.10.2013 ATC-Classification Quetiapine (N05AH04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.05. Show package size 60 Tablette(n) Index Therapeuticus (Swissmedic) 01.05. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 141.64 Limitation Yes Limitation text
Deductible 10 % Consumer price 170.45 Feedback FB Daily cost GTIN 7680632550086 Medication Code Synthetika Pharmacode 5828034 Disponibility
Composition quetiapinum 400 mg ut quetiapini fumaras 460.5 mg, lactosum monohydricum 15.5 mg, cellulosum microcristallinum, natrii citras dihydricus corresp. natrium 23.451 mg, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Quetiapine 400 mg
BAG: Active Agent Dose Quetiapine 400 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum E 171 color. Hypromellosum Überzug Lactose Monohydrate 15.5 mg Macrogol 400 Magnesii Stearas Natrii Citras Dihydricus Pro Compresso Obducto
Source Data was imported : 08.01.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
